XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues        
Net product revenues $ 277,113 $ 117,870 $ 460,912 $ 357,721
License revenues 6,030,561 45,010 6,073,335 3,144,698
Total revenues 6,307,674 162,880 6,534,247 3,502,419
Cost of revenues        
License revenue sharing 289,463 289,463
Cost of product revenues 80,277 28,521 142,931 101,079
Total cost of revenues 80,277 317,984 142,931 390,542
Gross margin 6,227,397 (155,104) 6,391,316 3,111,877
Patent Monetization expenses 343,846 10,074 5,519,307 1,734,245
Research and development expenses 199,698 182,335 627,990 562,383
General, administrative and selling expenses 334,161 295,916 989,846 960,271
Operating income (loss) 5,349,692 (643,429) (745,827) (145,022)
Interest (expense) income, net (35,227) 3,228 (65,137) 5,855
Income (loss) from operations before provision for income taxes 5,314,465 (640,201) (810,964) (139,167)
Provision (benefit) for income taxes 3,514 (38,710) 10,294 9,316
Net income (loss) $ 5,310,951 $ (601,491) $ (821,258) $ (148,483)
Basic weighted average shares 64,914,935 64,914,935 64,914,935 64,741,959
Basic net income (loss) per share $ 0.08 $ (0.01) $ (0.01) $ 0.00
Diluted weighted average shares 72,023,732 64,914,935 64,914,935 64,741,959
Diluted net income (loss) per share $ 0.07 $ (0.01) $ (0.01) $ 0.00